SCHEMBL1699226

SCHEMBL1699226

CCc1c(C)cnc2c1[nH]c(=O)n2-c1ccc(Oc2cn3ccccc3n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
PKM P14618 3/20 0.35
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 7/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
PDE10A Q9Y233 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
NTRK1 P04629 3/20 0.32
NTRK2 Q16620 3/20 0.32
NTRK3 Q16288 2/20 0.32
IGF1R P08069 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699182 0.85 NPC1 (0.37) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL1699084 0.75 DRD1 (0.39) PDE10AMEN1KMT2ALMNA
SCHEMBL1699264 0.73 MAP3K11 (0.40) ALDH1A1PKMMAPK1KDM4EMEN1
SCHEMBL9981087 0.73 SMN1; SMN2 (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL9982230 0.69 SMN1; SMN2 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL1699174 0.66 NPC1 (0.51) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL1699528 0.66 NPC1 (0.51) NPC1RAB9ASMN1; SMN2PKMKDM4E
SCHEMBL1699248 0.66 DRD1 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL10431770 0.66 KDM4E (0.64) ALDH1A1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL9981884 0.66 GSK3B (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585462-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2013-05-01 EP disclosed
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed